Table 2.
Etiology | Renal Klotho | Systemic Klotho | Comment | Reference | |||
---|---|---|---|---|---|---|---|
Protein | mRNA | Plasma | Urine | ||||
Animal model | |||||||
CKD | Npx + IRI | ↓ | ↓ | ↓ | ↓ | Klotho protein assayed by IB | 59 |
CKD | 5/6 Npx | ↓ | Assayed by NB | 88 | |||
CKD | ICGN | ↓ | Assayed by RT-qPCR | 138 | |||
CKD | Npx | ↓ | ↓ | ↓ | Subtotal Npx in apo-E−/− mice Plasma Klotho assayed by ELISA |
184 | |
DM | Streptozotocin | ↓ | Assayed by RT-qPCR | 142 | |||
DM | OLETF | ↓ | Assayed by NB | 141 | |||
DM | db/db | ↓ | ↓ | Klotho decreases inflammation in the kidney of db/db | 139 | ||
Hypertension | SHR | ↓ | Assayed by NB | 141 | |||
Hypertension | DOCA | ↓ | Assayed by NB | 141 | |||
Hypertension | Ang II | ↓ | ↓ | Klotho mRNA assayed by NB | 180 | ||
Hypertension | Ang II | ↓ | ↓ | Klotho mRNA assayed by RT-qPCR | 185 | ||
Hypertension | SHR | ↓ | ↓ | Klotho gene delivery decreases blood pressure | 140 | ||
Human subject | |||||||
CKD | CGN | ↓ | ↓ | Etiologies are not shown; assayed by NB, IB, and IHC | 88 | ||
CKD | DN | ↓ | ↓ | Assayed by NB, IB, and IHC | 88 | ||
Graft rejection | CGR | ↓ | ↓ | Assayed by NB, IB, and IHC | 88 | ||
CKD | N/A | ↓ | Assayed by ELISA and starts to reduce in early CKD | 85 | |||
CKD | N/A | ↑ | Assayed by ELISA and increases in early CKD | 144 | |||
CKD | N/A | ↑ | Assayed by ELISA and increases in CKD | 186 | |||
CKD | DN | ↓ | Assayed by ELISA | 186 | |||
CKD | N/A | ↓ | Assayed by IB and starts to decrease in early CKD | 59 | |||
CKD | DN | ↓ | RT-qPCR and starts to decrease in early CKD | 142 | |||
CKD | IgA nephropathy | ↓ | Only in advanced CKD | 142 | |||
CKD | MCD | ↓ | Only in advanced CKD | 142 | |||
ADPKD | ↓ | Assayed by ELISA and starts to reduce in early CKD | 86 | ||||
CKD | N/A | ↔ | No reduction in early CKD | 86 |
Abbreviations: ADPKD, autosomal dominant polycystic kidney disease; Ang II, angiotensin II; apo-E, apolipoprotein E; CKD, chronic kidney disease; CGN, chronic glomerulonephritis; CGR, chronic glomerulonephritis; DM, diabetes mellitus; DN, diabetic nephropathy; DOCA, deoxycorticosterone acetate; ELISA, enzyme-linked immunosorbent assay; IB, immunoblot; ICGN, Institute for Cancer Research–derived (spontaneous) glomerulonephritis; IgA, immunoglobulin A; IHC, immunohistochemistry; IRI, ischemia-reperfusion injury; MCD, minimal change disease; N/A, no information available; NB, Northern blot; Npx, nephrectomy; OLETF, Otsuka Long-Evans Tokushima fatty (rat); RT-qPCR, reverse transcription quantitative polymerase chain reaction; SHR, spontaneous hypertension.